Peptide therapeutics reach the UAE through one compliant route: EDE classification, registration, and importation under a licensed importer with cold chain handling. We run that route end to end, under our own licences.
Peptide therapeutics are the fastest-growing import category we see: metabolic medicine led by GLP-1 products, aesthetic indications, and longevity products, all arriving at once. Demand has moved faster than most supply chains' understanding of the rules.
The regulatory difficulty is structural. A peptide can be a biological medicinal product or a conventional pharmaceutical, and the UAE does not decide by molecule class. The EDE classifies each product case by case. Until that decision exists, nobody can tell you the registration route, the data expectations, or the timeline.
That is why peptide registration in the UAE starts somewhere specific: a classification file, not a marketing plan.
Three possible outcomes, one decision that sets the whole pathway.
One outcome: the EDE treats the peptide as a biological, and registration follows the biologics route with its own evidence expectations.
The product registers as a conventional pharmaceutical through the standard EDE product registration route.
Some products are found not eligible for registration. We tell you early, before money is spent on a market that is closed to the product.
There is no blanket peptide rule. The EDE decides each product on its own file, and a result for one peptide does not transfer to the next.
We compile the classification file, submit it to the EDE, and obtain the decision in writing before anything else is filed.
The outcome sets the registration route, the evidence expectations, and the timeline. Everything downstream depends on it.
Each stage depends on the one before it. We run all five.
Compile and submit the classification file. The written decision sets the route for everything that follows.
Register the manufacturing site with the EDE, a one-off step per site with 5-year validity.
Prepare and submit the registration dossier, with documents in English and Arabic, through to certificate issuance.
Obtain the EDE import permit under our licence and bring the shipment in under cold chain conditions.
Receive into our GDP warehouse and distribute to licensed facilities only.
Unregistered peptide importation risks seizure and penalties. Under UAE law, only entities holding a pharmaceutical facility or medical warehouse licence, with the corresponding EDE import permit, may import pharmaceutical products. A shipment outside that framework has no legal route into the country.
The compliant route exists, and it is well defined: classification, site registration, product registration, an import permit, and cold chain receipt into a licensed warehouse. We run every stage under our own licences, as a licensed partner, not a paperwork consultancy. If your current supply sits outside the framework, we can move it onto the registered pathway.
CTD dossier preparation and technical committee submissions through to certificate issuance.
Importation under our own licensed facility, medical warehouse, and importer credentials.
Every EDE service explained: classification, registration, permits, and facility licensing.
Send us the product details and we will come back with a roadmap, classification opinion, and indicative timeline within 48 hours.
Talk to our regulatory team